Supreme Pharmaceuticals Inc. (CSE:SL) CEO David Stadnyk Talks Plans of “Aggressively Pursuing Acquisitions”

Supreme Pharmaceuticals Inc. (CSE:SL) CEO David Stadnyk spoke to Cannabis Investing News at the GreenRush Financial Conference about their “aggressive acquisition” plans – with companies that are “up and running”. This has already begun with the producing medical marijuana facility in the South Okanagan, which is in the last phase of the approval process.

Supreme Pharmaceuticals Inc. is a company dedicated to securing multiple producing medical marijuana facilities in Canada and applying for several MMPR commercial production licences. Pursuing these opportunities will provide the most long-term shareholder value.